238 related articles for article (PubMed ID: 17408727)
1. The role of cytoreductive surgery for colon cancer metastatic to the ovary.
McCormick CC; Giuntoli RL; Gardner GJ; Schulick RD; Judson K; Ronnett BM; Vang R; Bristow RE
Gynecol Oncol; 2007 Jun; 105(3):791-5. PubMed ID: 17408727
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
Zhao JZ; Wang G; Zhang RP; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
[TBL] [Abstract][Full Text] [Related]
3. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
4. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
5. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
Bristow RE; Duska LR; Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
[TBL] [Abstract][Full Text] [Related]
6. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
7. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Bristow RE; Montz FJ
Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
Jiang R; Tang J; Cheng X; Zang RY
Eur J Surg Oncol; 2009 Jan; 35(1):92-7. PubMed ID: 18632244
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
10. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries.
Kim WY; Kim TJ; Kim SE; Lee JW; Lee JH; Kim BG; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):97-101. PubMed ID: 20018420
[TBL] [Abstract][Full Text] [Related]
11. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
12. Synchronous ovarian metastases at the time of laparotomy for colon cancer.
Wright JD; Powell MA; Mutch DG; Rader JS; Gibb RK; Huettner PC; Herzog TJ
Gynecol Oncol; 2004 Mar; 92(3):851-5. PubMed ID: 14984952
[TBL] [Abstract][Full Text] [Related]
13. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
15. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
[TBL] [Abstract][Full Text] [Related]
16. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.
Salani R; Zahurak ML; Santillan A; Giuntoli RL; Bristow RE
Gynecol Oncol; 2007 Dec; 107(3):495-9. PubMed ID: 17854870
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
[TBL] [Abstract][Full Text] [Related]
18. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
[TBL] [Abstract][Full Text] [Related]
19. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer with metastasis to the ovary at time of initial diagnosis.
Miller BE; Pittman B; Wan JY; Fleming M
Gynecol Oncol; 1997 Sep; 66(3):368-71. PubMed ID: 9299247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
